Gene Discovery Core, The Manton Center for Undiagnosed and Rare Conditions
This observational study at Boston Children's Hospital aims to understand the genetic causes of rare, poorly understood, or undiagnosed conditions. Researchers hope to identify new disease-causing genes and better describe these conditions, which could lead to improved diagnosis and treatment in the future. You may be eligible if you have a known or uncertain rare diagnosis that might have a genetic cause, or if you are a relative of someone with such a diagnosis. The study is looking to enroll up to 10,000 participants. The study's success will be measured by identifying rare or new genetic changes causing disorders and by describing the symptoms of these conditions over 1 to 10 years.
- Study design
- This is an observational study aiming to enroll up to 10,000 participants. It does not involve a specific intervention or drug.
- What's involved
- You would provide DNA and tissue samples (if available), and allow access to your medical records and genomic data. You would also provide relevant medical information, family history, and blood/saliva samples.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study aims to identify genetic variants and characterize clinical features over 1 to 10 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Gene Discovery Core, The Manton Center
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Identification of rare or novel disease-causing genetic variants for a participant's disorder1-10 years
Functional analysis, including animal modeling and cell line assays, will be performed for novel candidate genes. When a molecular diagnosis is identified for a family, this is reported back through a designated health care provider.
- Characterization of clinical features of novel and rare disorders using Human Phenotype Ontology (HPO) terms1-10 years
As known and new disease genes are identified the resulting genotypes are correlated with subject phenotypes.